摘要
变应性鼻炎（allergic rhinitis,AR）影响着全球10%～40%的人口,其中15%～18%的AR患者伴随有哮喘。虽然AR并不引起严重的机体和功能损伤,但是却在全世界范围内导致了沉重的医疗负担。《变应性鼻炎及其对哮喘的影响》（allergic rhinitis and its impact on asthma,ARIA）始于1999年WHO的一次工作会议,
＂Allergic rhinitis and its impact on asthma （ARIA）＂ has been the most preferred reference for national guidelines. The ARIA 2010 revision is the first evidence-based clinical guideline in the field of allergies, which has great influence in the world. The ARIA 2016 revision continues the basic framework of the 2010 revision, which focuses on six controversial clinical issues in the treatment of allergic rhinitis. It aimed to provide clear informationand systematic treat- ment for patients, clinicians and health policy makers. The interpretation of the ARIA 2016 revision will help domestic otolaryngologist, respiratory doctors, and allergy practitioners understand the latest guidelines for AR drug treatment in the world.
出处
《临床耳鼻咽喉头颈外科杂志》
CAS
北大核心
2017年第17期1327-1329,共3页
Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词
鼻炎
变应性
哮喘
药物治疗
rhinitis, allergic
asthma
drug treatment
